Citations

Clear

367 citation(s) found for "Su, Pan".

Impact of Antimicrobial Dipping Solutions on Postoperative Infection Rates in Patients with Diabetes Undergoing Primary Insertion of a Coloplast Titan Inflatable Penile Prosthesis
Towe, Maxwell , Huynh, Linda My , Osman, Mohamad M. , El‐Khatib, Farouk M. , Andrianne, Robert, Barton, Gregory J. , Campbell, Jeffrey , Clavell-Hernández, Jonathan , Connor, Jessica, Gross, Martin , Guillum, Ross, Guise, Amy, Hatzichristodoulou, Georgios , Henry, Gerard D., Hsieh, Tung-Chin, Jenkins, Lawrence C. , Koprowski, Christopher D. , Lee, Kook B., Lentz, Aaron , Munarriz, Ricardo , Osmonov, Daniar , Pan, Shu, Parikh, Kevin , Park, Sung Hun , Patel, Amir Shareza, Perito, Paul , Sadeghi‐Nejad, Hossein , Sempels, Maxime, Simhan, Jay , Wang, Run , Yafi, Faysal A. , Broderick, Gregory, Jenkins, Lawrence , Broderick, Gregory A. , Burnett, Arthur L. “Bud” , Connor, Jessica, Hsieh, Tung‐Chin

Mayo Clinic

The Journal of Sexual Medicine | August 15, 2020 | Volume: 17 | Issue: 10 | Pages: 2077-2083

10.1016/j.jsxm.2020.07.009 | PMID 32807707 Get It

Abstract Background Modern-day penile prostheses use infection retardant coating to decrease rates of postoperative infection, subsequently reducing explantation and revision rates as well. The Coloplast Titan models are dipped into antimicrobial solutions right before implantation, and the components used for dipping can be tailored toward the patient. Aim To compare infection, explantation, and revision rates among different dipping solutions used before implantation for patients with diabetes receiving a Coloplast Titan implant. Methods We systematically reviewed 932 patients with diabetes receiving a primary penile implant across 18 different centers from the period April 2003 to August 2018. Of those patients, 473 received a Coloplast device, whereas 459 received an AMS device. Data regarding the type of antimicrobial solution used before implantation were recorded for 468 patients receiving a Coloplast Titan, including whether or not they suffered a postoperative infection and if they underwent explantation and/or revision. Outcome rates were compared using Fisher’s exact and Pearson’s chi-square tests, and logistic regression modeling was performed to account for covariates. Outcomes The main outcome measures of this study were postoperative infection, explantation, and revision rates. Results Of the total 932 patients reviewed, 33 suffered a postoperative infection. Of 468 patients receiving Coloplast implants, there was a 3.4% infection rate. The most commonly used antibiotic combination before dipping was vancomycin + gentamicin (59.0%). There was a significantly lower rate of postoperative infection, explantation, and revision when vancomycin + gentamicin was used than those associated with the use of all other dipping solutions ([1.4% vs 6.4%; P = .004], [1.1% vs 8.3%; P < .001], and [2.5% vs 12.5; P < .001], respectively). After adjusting for age, body mass index, preoperative blood glucose level, and hemoglobin A1c, the use of other dips was an independent predictor of postoperative infection (odds ratio: 0.191; P = .049). The inclusion of rifampin in the dipping solution trended toward being a significant risk factor for infection (P = .057). Including antifungals in the dipping solution did not affect infection (P = .414), explantation (P = .421), or revision (P = .328) rates. Clinical Implications Vancomycin + gentamicin was the most efficacious combination of antibiotics used for dipping in terms of preventing postoperative infection and subsequent explantation and revision. Strengths and Limitations Data were sampled across multiple institutions providing a large sample that may be more representative of the population of interest. A key limitation of the study was its retrospective nature, which prevented us from controlling certain variables. Conclusion The use of rifampin did not provide the same type of protection, possibly representing a shift in resistance patterns of common bacteria responsible for device infection.
Accelerometer Measurements Indicate That Arm Movements of Children With Cerebral Palsy Do Not Increase After Constraint-Induced Movement Therapy (CIMT)
Goodwin, Brianna M. , Sabelhaus, Emily K., Pan, Ying-Chun , Pham, Kelly, Walker, William O., Bjornson, Kristie F , Walker, William O., Steele, Katherine M.

Mayo Clinic

American Journal of Occupational Therapy | August 7, 2020 | Volume: 74 | Issue: 5 | Pages: 1146-1155

10.5014/ajot.2020.040246 | PMID 32804628 Get It

Importance: Constraint-induced movement therapy (CIMT) is a common treatment for children with unilateral cerebral palsy (CP). Although clinic-based assessments have demonstrated improvements in arm function after CIMT, whether these changes are translated and sustained outside of a clinic setting remains unclear. Objective: Accelerometers were used to quantify arm movement for children with CP 1 wk before, during, and 4 wk or more after CIMT; measurements were compared with those from typically developing (TD) peers. Design: Observational. Setting: Tertiary hospital and community. Participants: Seven children with CP (5 boys, 2 girls; average [ AVE ] age ± standard deviation [ SD ] = 7.4 ± 1.2 yr) and 7 TD peers (2 boys, 5 girls; AVE age ± SD = 7.0 ± 2.3 yr). Intervention: 30-hr CIMT protocol. Outcomes and Measures: Use ratio, magnitude ratio, and bilateral magnitude were calculated from the accelerometer data. Clinical measures were administered before and after CIMT, and parent surveys assessed parent and child perceptions of wearing accelerometers. Results: During CIMT, the frequency and magnitude of paretic arm use among children with CP increased in the clinic and in daily life. After CIMT, although clinical scores showed sustained improvement, the children’s accelerometry data reverted to baseline values. Children and parents in both cohorts had positive perceptions of accelerometer use. Conclusions and Relevance: The lack of sustained improvement in accelerometry metrics after CIMT suggests that therapy gains did not translate to increased movement outside the clinic. Additional therapy may be needed to help transfer gains outside the clinic. What This Article Adds: Accelerometer measurements were effective at monitoring arm movement outside of the clinic during CIMT and suggested that additional interventions may be needed after CIMT to sustain benefits.
Reproducible Artificial Intelligence Research Requires Open Communication of Complete Source Code
Kitamura, Felipe , Pan, Ian , Kline, Timothy L. , Kitamura, Felipe C

Mayo Clinic

Radiology: Artificial Intelligence | July 29, 2020 | Volume: 2 | Issue: 4 | Pages: e200060

10.1148/ryai.2020200060 | PMID 33937836 Get It

Renal Survival in Children with Glomerulonephritis with Crescents: A Pediatric Nephrology Research Consortium Cohort Study
Maliakkal, Joseph , Hicks, John , Michael, Mini , Selewski, David T. , Twombley, Katherine , Rheault, Michelle N. , Seamon, Meredith, Misurac, Jason , Tran, Cheryl L. , Reyes, Loretta , Onder, Ali Mirza , Constantinescu, Alexandru R. , Singh, Vaishali , Pan, Cynthia G., Omoloja, Abiodun , Wu, Qiang , Smoyer, William E., Hidalgo, Guillermo , Wenderfer, Scott E. , Misurac, Jason M , Wenderfer, Scott E , Twombley, Katherine E , Flynn, Joseph T. , Smoyer, William E.

Mayo Clinic

Journal of Clinical Medicine | July 27, 2020 | Volume: 9 | Issue: 8 | Pages: 2385

10.3390/jcm9082385 | PMID 32722612 Get It

There is no evidence-based definition for diagnosing crescentic glomerulonephritis. The prognostic implications of crescentic lesions on kidney biopsy have not been quantified. Our objective was to determine risk factors for end-stage kidney disease (ESKD) in patients with glomerulonephritis and crescents on kidney biopsy. A query of the Pediatric Nephrology Research Consortium’s Pediatric Glomerulonephritis with Crescents registry identified 305 patients from 15 centers. A retrospective cohort study was performed with ESKD as the primary outcome. Median age at biopsy was 11 years (range 1–21). The percentage of crescents was 3–100% (median 20%). Etiologies included IgA nephropathy (23%), lupus (21%), IgA vasculitis (19%) and ANCA-associated GN (13%), post-infectious GN (5%), and anti-glomerular basement membrane disease (3%). The prevalence of ESKD was 12% at one year and 16% at last follow-up (median = 3 years, range 1–11). Median time to ESKD was 100 days. Risk factors for ESKD included %crescents, presence of fibrous crescents, estimated GFR, and hypertension at biopsy. For each 1% increase in %crescents, there was a 3% decrease in log odds of 1-year renal survival (p = 0.003) and a 2% decrease in log odds of renal survival at last follow-up (p < 0.001). These findings provide an evidence base for enrollment criteria for crescentic glomerulonephritis in future clinical trials.
Ethics and informatics in the age of COVID-19: challenges and recommendations for public health organization and public policy
Subbian, Vignesh , Clarkson, Melissa D. , Rahimzadeh, Vasiliki , Petersen, Carolyn , Schreiber, Richard , DeMuro, Paul R. , Dua, Prerna, Goodman, Kenneth W. , Kaplan, Bonnie J. , Lehmann, Christoph U. , Pan, Eric, Goodman, Kenneth W , Lehmann, Christoph U , Petersen, Carolyn , Subbian, Vignesh , Solomonides, Anthony , Kaplan, Bonnie, Koppel, Ross , Senathirajah, Yalini

Mayo Clinic

Journal of the American Medical Informatics Association | July 24, 2020 | Volume: 28 | Issue: 1 | Pages: 184-189

10.1093/jamia/ocaa188 | PMID 32722749 Get It

AbstractThe COVID-19 pandemic response in the United States has exposed significant gaps in information systems and processes that prevent timely clinical and public health decision-making. Specifically, the use of informatics to mitigate the spread of SARS-CoV-2, support COVID-19 care delivery, and accelerate knowledge discovery bring to the forefront issues of privacy, surveillance, limits of state powers, and interoperability between public health and clinical information systems. Using a consensus-building process, we critically analyze informatics-related ethical issues in light of the pandemic across 3 themes: (1) public health reporting and data sharing, (2) contact tracing and tracking, and (3) clinical scoring tools for critical care. We provide context and rationale for ethical considerations and recommendations that are actionable during the pandemic and conclude with recommendations calling for longer-term, broader change (beyond the pandemic) for public health organization and policy reform.
Abnormal Endothelial Gene Expression Associated With Early Coronary Atherosclerosis
Hebbel, Robert P. , Wei, Peng , Milbauer, Liming , Solovey, Anna, Kiley, James P., Pattee, Jack , Lerman, Lilach O. , Pan, Wei , Lerman, Amir , Wei, Peng , Lerman, Amir , Corban, Michel , Kiley, James

Mayo Clinic

Journal of the American Heart Association | July 16, 2020 | Volume: 9 | Issue: 14 | Pages: No page available

10.1161/jaha.120.016134 | PMID 32673514 Get It

Background We examined feasibility of a unique approach towards gaining insight into heritable risk for early atherosclerosis: surveying gene expression by endothelial cells from living subjects. Methods and Results Subjects aged <50 years (mean age, 37; range, 22–49) without obstructive coronary artery disease underwent coronary reactivity testing that identified them as having normal or abnormal coronary endothelial function. Cultures of Blood Outgrowth Endothelial Cells (BOEC) from 6 normal and 13 abnormal subjects passed rigorous quality control and were used for microarray assessment of gene expression. Of 9 genes differentially expressed at false discovery rate <0.1%, we here focus upon abnormal subjects having elevated expression of HMGB1 (high mobility group box 1) which we unexpectedly found to be linked to low LAMC1 (laminin gamma 1) expression. This linkage was corroborated by 3 of our past studies and confirmed bio‐functionally. Compared with normal BOEC, abnormal BOEC released 13±3‐fold more HMGB1 in response to lipopolysaccharide; and they deposited one tenth as much LAMC1 into collagen subendothelial matrix during culture. Clinical follow‐up data are provided for 4 normal subjects (followed 13.4±0.1 year) and for 12 abnormal subjects (followed 9.1±4.5 years). Conclusions The known pathogenic effects of high‐ HMGB1 and low‐ LAMC1 predict that the combination would biologically converge upon the focal adhesion complex, to the detriment of endothelial shear responsiveness. This gene expression pattern may comprise a heritable risk state that promotes early coronary atherosclerosis. If so, the testing could be applied even in childhood, enabling early intervention. This approach offers a way to bridge the information gap between genetics and clinical phenotype.
Triage of patients with venous and lymphatic diseases during the COVID-19 pandemic – The Venous and Lymphatic Triage and Acuity Scale (VELTAS)
Parsi, Kurosh , Rij, André M. van , Meissner, Mark H. , Gloviczki, Péter , Benson, Stephen, Bottini, Oscar, Canata, Victor , Dinnen, Paul, Gasparis, Antonios, Gianesini, Sergio , Lal, Brajesh K. , Kabnick, Lowell S , Marston, William A. , Granados, Alberto Martinez, Morrison, Nick , Paraskevas, P, Patel, Malay , Roberts, Stefania , Komlos, Pedro, Varghese, Roy , Welch, Harold J. , Wittens, Cees H.A. , Parsi, Kurosh , Davies, Alun H. , Maeseneer, Marianne De , Huber, David, Jenkins, David, Lim, Adrian, Nicolaides, Andrew , Rogan, Christopher , Schul, Marlin W. , Stirling, Andy , Thibault, Simon , Gloviczki, Péter

Mayo Clinic

Phlebology: The Journal of Venous Disease | July 8, 2020 | Volume: 35 | Issue: 8 | Pages: 550-555

10.1177/0268355520930884 | PMID 32639862 Get It

The coronavirus disease 2019 (COVID-19) global pandemic has resulted in diversion of healthcare resources to the management of patients infected with SARS-CoV-2 virus. Elective interventions and surgical procedures in most countries have been postponed and operating room resources have been diverted to manage the pandemic. The Venous and Lymphatic Triage and Acuity Scale was developed to provide an international standard to rationalise and harmonise the management of patients with venous and lymphatic disorders or vascular anomalies. Triage urgency was determined based on clinical assessment of urgency with which a patient would require medical treatment or surgical intervention. Clinical conditions were classified into six categories of: (1) venous thromboembolism (VTE), (2) chronic venous disease, (3) vascular anomalies, (4) venous trauma, (5) venous compression and (6) lymphatic disease. Triage urgency was categorised into four groups and individual conditions were allocated to each class of triage. These included (1) medical emergencies (requiring immediate attendance), example massive pulmonary embolism; (2) urgent (to be seen as soon as possible), example deep vein thrombosis; (3) semi-urgent (to be attended to within 30–90 days), example highly symptomatic chronic venous disease, and (4) discretionary/non-urgent- (to be seen within 6–12 months), example chronic lymphoedema. Venous and Lymphatic Triage and Acuity Scale aims to standardise the triage of patients with venous and lymphatic disease or vascular anomalies by providing an international consensus-based classification of clinical categories and triage urgency. The scale may be used during pandemics such as the current COVID-19 crisis but may also be used as a general framework to classify urgency of the listed conditions.
Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients
Peng, Hong , Pan, Sheng, Yan, Yuanqing , Brand, Randall E. , Petersen, Gloria M. , Chari, Suresh T. , Lai, Lisa A. , Eng, Jimmy K. , Brentnall, Teresa A. , Chen, Ru , Brand, Randall E , Chari, Suresh T

Mayo Clinic

Cancers | June 15, 2020 | Volume: 12 | Issue: 6 | Pages: 1534

10.3390/cancers12061534 | PMID 32545216 Get It

Background: Diabetes is a risk factor associated with pancreatic ductal adenocarcinoma (PDAC), and new adult-onset diabetes can be an early sign of pancreatic malignancy. Development of blood-based biomarkers to identify diabetic patients who warrant imaging tests for cancer detection may represent a realistic approach to facilitate earlier diagnosis of PDAC in a risk population. Methods: A spectral library-based proteomic platform was applied to interrogate biomarker candidates in plasma samples from clinically well-defined diabetic cohorts with and without PDAC. Random forest algorithm was used for prediction model building and receiver operating characteristic (ROC) curve analysis was applied to evaluate the prediction probability of potential biomarker panels. Results: Several biomarker panels were cross-validated in the context of detection of PDAC within a diabetic background. In combination with carbohydrate antigen 19-9 (CA19-9), the panel, which consisted of apolipoprotein A-IV (APOA4), monocyte differentiation antigen CD14 (CD14), tetranectin (CLEC3B), gelsolin (GSN), histidine-rich glycoprotein (HRG), inter-alpha-trypsin inhibitor heavy chain H3 (ITIH3), plasma kallikrein (KLKB1), leucine-rich alpha-2-glycoprotein (LRG1), pigment epithelium-derived factor (SERPINF1), plasma protease C1 inhibitor (SERPING1), and metalloproteinase inhibitor 1 (TIMP1), demonstrated an area under curve (AUC) of 0.85 and a two-fold increase in detection accuracy compared to CA19-9 alone. The study further evaluated the correlations of protein candidates and their influences on the performance of biomarker panels. Conclusions: Proteomics-based multiplex biomarker panels improved the detection accuracy for diagnosis of early stage PDAC in diabetic patients.
Survival prediction for oral tongue cancer patients via probabilistic genetic algorithm optimized neural network models
Yang, Qingping , Rwigema, Jean-Claude M., Qi, X. Sharon , Pan, Xiaoying , Zhang, Ting , Yang, Di

Mayo Clinic

The British Journal of Radiology | June 10, 2020 | Volume: 93 | Issue: 1112 | Pages: No page available

10.1259/bjr.20190825 | PMID 32520585 Get It

Objectives: High throughput pre-treatment imaging features may predict radiation treatment outcome and guide individualized treatment in radiotherapy (RT). Given relatively small patient sample (as compared with high dimensional imaging features), identifying potential prognostic imaging biomarkers is typically challenging. We aimed to develop robust machine learning methods for patient survival prediction using pre-treatment quantitative CT image features for a subgroup of head-and-neck cancer patients. Methods: Three neural network models, including back propagation (BP), Genetic Algorithm-Back Propagation (GA-BP), and Probabilistic Genetic Algorithm-Back Propagation (PGA-BP) neural networks were trained to simulate association between patient survival and radiomics data in radiotherapy. To evaluate the models, a subgroup of 59 head-and-neck patients with primary cancers in oral tongue area were utilized. Quantitative image features were extracted from planning CT images, a novel t-Distributed Stochastic Neighbor Embedding (t-SNE) method was used to remove irrelevant and redundant image features before fed into the network models. 80% patients were used to train the models, and remaining 20% were used for evaluation. Results: Of the three supervised machine-learning methods studied, PGA-BP yielded the best predictive performance. The reported actual patient survival interval of 30.5 ± 21.3 months, the predicted survival times were 47.3 ± 38.8, 38.5 ± 13.5 and 29.9 ± 15.3 months using the traditional PCA. Combining with the novel t-SNE dimensionality reduction algorithm, the predicted survival intervals are 35.8 ± 15.2, 32.3 ± 13.1 and 31.6 ± 15.8 months for the BP, GA-BP and PGA-BP neural network models, respectively. Conclusion: The work demonstrated that the proposed probabilistic genetic algorithm optimized neural network models, integrating with the t-SNE dimensionality reduction algorithm, achieved accurate prediction of patient survival. Advances in knowledge: The proposed PGA-BP neural network, integrating with an advanced dimensionality reduction algorithm (t-SNE), improved patient survival prediction accuracy using pre-treatment quantitative CT image features of head-and-neck cancer patients.